2017
“A qualitative analysis of the barriers to antiretroviral therapy initiation among children 2 to 18 months of age in Swaziland.” Swaziland. African Journal of AIDS Research (AJAR). This MOH study was conducted in collaboration with the University of Alabama of Birmingham and funded by UNICEF.
“The collaborative African genomics network training program: a trainee perspective on training the next generation of African scientists. Uganda. Journal of American College of Medical Genetics and Genomics (April 2017).
TXCH Global HOPE; Apr 10, 2017; me; English; Bristol-Myers-Squibb Foundation Secure the Future Learning and Sharing Conference, Emoyeni Conference Center, Johannesburg, South Africa
The Botswana Story; Apr 29, 2017; me; English; 2017 Global Health Catalyst Cancer Summit, Dana- Farber/Harvard Cancer Center, Yawkey Center, Boston, MA, USA
Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe Malawi. El-Mallawany, NK Mutai M, Mtete I, Gopal S, Stanley C, Mtunda M, Chasela M, Kamiyango W. Villiera J, Wassa P, Fedoriw Y, Montgomery N, Liomba G, Kampani C, Krysiak R, Westmoreland K, K, Kim M, Slone JS, Lubega J, Scheurer M, Allen C, Mehta P, Kazember P. Global Pediatric Health, 4, 2333794X17715813
2016
Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. El-Mallawany NK, Kamiyango W, Slone JS, Villiera J, Kovarik CL, Cox CM, et al. (2016). PLoS ONE. 11(4): e0153335.
2015
Brief Report: Impact of Option B+ on the Infant PMTCT Cascade in Lilongwe, Malawi. Kim MH, Ahmed S, Hosseinipour MC, Yu X, Nguyen C, Chimbwandira F, Paul ME, Kazembe PN, Abrams EJ. J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):99-103.
2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial Musiime V, Cook A, Kayiwa J, Zangata D, Nansubuga C, Arach B, Kenny J, Wavamunno P, Komunyena J, Kabamba D, Asiimwe AR, Mirembe G, Abongomera G, Mulenga V, Kekitiinwa A, Kityo C, Walker SA, Klein N, Gibb DM; CHAPAS-3 trial team Antivir Ther. 2014;19(3):269-76
Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-Infected African Children after Three Years on First-Line Antiretroviral Therapy Bwakura-Dangarembizi M, Musiime V, Szubert AJ, Prendergast AJ, Gomo ZA, Thomason MJ, Musarurwa C, Mugyenyi P, Nahirya P, Kekitiinwa A, Gibb DM, Walker AS, Nathoo K; for the ARROW Trial Team. Pediatr Infect Dis J. 2014 Jul 25. [Epub ahead of print]
Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over study Giaquinto C, Anabwani G, Feiterna-Sperling C, Nuttall J, Mompati K, Königs C, Mensa FJ, Sabo JP, Yong CL, MacGregor TR, Nguyen T, Quinson AM Pediatr Infect Dis J. 2014 Jul;33(7):e173-9
The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children Musiime V, Fillekes Q, Kekitiinwa A, Kendall L, Keishanyu R, Namuddu R, Young N, Opilo W, Lallemant M, Walker AS, Burger D, Gibb DM J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):148-54
Tuberculosis in pediatric antiretroviral therapy programs in low- and middle-income countries: diagnosis and screening practices Ballif M, Renner L, Dusingize JC, Leroy V, Ayaya S, Wools-Kaloustian K, Cortes CP, McGowan CC, Graber C, Mandalakas AM, Mofenson LM, Egger M, Kumara Wati KD, Nallusamy R, Reubenson G, Davies M, Fenner L, for the International epidemiologic Databases to Evaluate AIDS (IeDEA) Journal of the Pediatric Infectious Disease Society. Epub ahead of print, 28 March 2014.
2013
Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and alive Kellerman SE, Ahmed S, Feeley-Summerl T, Jay J, Kim M, Phelps BR, Sugandhi N, Schouten E, Tolle M, Tsiouris F Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women, Mothers and Children. AIDS. 2013 Nov;27 Suppl 2:S225-33
Challenges in infant and young child nutrition in the context of HIV. Brewinski-Isaacs M; Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women, Mothers and Children Sint TT, Lovich R, Hammond W, Kim M, Melillo S, Lu L, Ching P, Marcy J, Rollins N, Koumans EH, Heap AN AIDS. 2013 Nov;27 Suppl 2:S169-77
Delivering pediatric HIV care in resource-limited settings: cost considerations in an expanded response Tolle MA, Phelps BR, Desmond C, Sugandhi N, Omeogu C, Jamieson D, Ahmed S, Reuben E, Muhe L, Kellerman SE, Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women, Mothers and Children. AIDS. 2013 Nov;27 Suppl 2:S179-86
HIV-exposed infants: rethinking care for a lifelong condition Sugandhi N, Rodrigues J, Kim M, Ahmed S, Amzel A, Tolle M, Dziuban EJ, Kellerman SE, Rivadeneira E, Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women, Mothers and Children AIDS. 2013 Nov;27 Suppl 2:S187-95
Improved dosing accuracy of liquid medication using a low-cost plastic clip for standard oral syringes Spiegel GJ, Dinh C, Gutierrez A, Lukomnik J, Lu B, Mirabal Y, Vestewig L, Marton S, Adler M, Schutze G, Wickham H, Oden M, Richards-Kortum R Ann Biomed Eng 2013;41: 1860-1868
Linkage, initiation and retention of children in the antiretroviral therapy cascade: an overview Phelps BR, Ahmed S, Amzel A, Diallo MO, Jacobs T, Kellerman SE, Kim MH, Sugandhi N, Tam M, Wilson-Jones M Child Survival Working Group of the Interagency Task Team on the Prevention, Treatment of HIV infection in Pregnant Women, Mothers, ChildAIDS. 2013 Nov;27 Suppl 2:S207-13
Nine-year follow-up of HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy Wanless RS, Rugină S, Ruţă SM, Dumitru IM, Cernat RC, Schwarzwald HL, Calles NR, Schutze GE,Schweitzer AM, Draper HR, Kline MW Germs. 2013 Sep 1;3(3):90-95
Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study Picat MQ, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, Nahirya Ntege P, Gibb DM, Thiebaut R, Walker AS, Klein N, Callard R; ARROW Trial Team PLoS Med. 2013 Oct;10(10):e1001542
Use of nucleoside reverse transcriptase inhibitor-only regimens in HIV-infected children and adolescents Neely M1, Rutstein R, Del Bianco G, Heresi G, Barton T, Wiznia A, Wiegand R, Wheeling T, Bohannon B, Dominguez K; LEGACY Consortium. Hernandez-Trujillo V, Laufer M, Demeritte D, Puga A, Martinez Y, Emmanuel P, Sullivan J, Sikes AJ, Rathore M, Alvarez A, Mirza A, Champion K, Trainer E, Paul ME, Foster SB, Leonard A Pediatr Infect Dis J. 2013 Sep;32(9):e370-6
2012
2011
Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, Aertker L, Chirwa M, Eliya M, Mofolo I, Hoffman I, Kazembe PN, van der Horst C, Kline MW and Hosseinipour MC J Acquir Immun Def Syndr (in press)